Biosimilars are biologic medicines that are highly similar to existing licensed biologic products with no clinically meaningful differences in the terms of safety and
...Leveraging digital health in the pharmaceutical industry opens up many possibilities for both trial researchers and participants. To start, the use of wearables,
...Prescription drugs sold in retail pharmacies accounted for almost $325 billion or 10% of total healthcare costs in 2015, up 9% from 2014.1 Such dramatic growth has
...Every pharmaceutical Track & Trace solution for existing systems must be customized to meet specific product line requirements, such as available space and
...Rising brand drug prices are behind the increase in prescription drug spending and patient costs. In 2016, brand drugs accounted for only 11 percent of prescriptions
...Moderna was ‘born’ at an auspicious time, in the midst of astonishing technological innovations. Digital technologies, such as Robotics, Automation, Artificial
...Emerging markets are a big opportunity for pharma companies. But from the R&D productivity standpoint, these markets create new challenges in genomic complexity. So, in research and clinic
...modum.io sensor devices record environmental conditions while physical products are in transit. When a change in ownership occurs, the collected data is checked
...Life sciences packaging needs have driven innovation in the coding and marking industry in the recent past and will continue to do so for the foreseeable future.
...